Regulatory T cells in Type 1 diabetes patients treated with IL-2

• Research type

  Research Study

• Full title

  Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D)

• IRAS ID

  115333

• Contact name

  Frank Waldron-Lynch

• Contact email

  frank.waldron-lynch@cimr.cam.ac.uk

• Sponsor organisation

  R&D manager, Cambridge University Hospitals

• REC name

  East of England - Cambridge Central Research Ethics Committee

• REC reference

  13/EE/0020

• Date of REC Opinion

  18 Feb 2013

• REC opinion

  Further Information Favourable Opinion